门窦血管性疾病的临床病程区别于特发性非肝硬化门脉高压
该研究回顾性分析了2000-2019年间维也纳总医院接受肝活检的患者,比较符合新提出的门窦血管性疾病(PSVD)标准与特发性非肝硬化门脉高压(INCPH)标准患者的临床特征和结局。结果显示PSVD患者中30.8%同时符合INCPH标准,INCPH+/PSVD+患者Child-Pugh评分更高、失代偿更常见,但PSVD整体临床病程较INCPH更有利,特异性门脉高压征象与肝失代偿和死亡相关。
要点
- PSVD诊断需结合典型组织学改变,30.8%患者同时符合INCPH标准。
- INCPH+/PSVD+患者基线Child-Pugh评分和失代偿率高于INCPH-/PSVD+。
- 特异性门脉高压临床征象(如静脉曲张和侧支循环)与肝失代偿和死亡相关。
核心结论
- 新PSVD标准有助于诊断,PSVD患者临床病程较INCPH更有利。
- 特异性门脉高压征象包括静脉曲张和侧支循环,与肝失代偿和死亡率相关。
研究设计与样本
- 回顾性研究,筛选2000-2019年维也纳总医院接受肝活检(基线)±肝静脉压力梯度(HVPG)测量的患者,依据PSVD和INCPH标准进行诊断。
主要发现
- 91例患者诊断为PSVD,其中28例(30.8%)同时符合INCPH标准(INCPH+/PSVD+)。
- 72例(79.1%)有特异性组织学改变,54例(59.3%)有特异性临床门脉高压征象。
临床怎么用
- 临床应结合组织学和门脉高压征象对PSVD进行诊断和风险分层。
- 存在静脉曲张或侧支循环等特异性门脉高压征象的PSVD患者需密切监测肝失代偿和死亡风险。
局限性
- 单中心回顾性研究,样本量有限,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Porto-sinusoidal vascular disease (PSVD) was recently proposed as novel clinical entity characterized by typical histological changes with or without portal hypertension (PH) in the absence of cirrhosis. Thus, we aimed to describe clinical characteristics and the outcome of PSVD patients and to compare these to patients meeting traditional idiopathic non-cirrhotic portal hypertension (INCPH) criteria. METHODS: Patients undergoing liver biopsy (baseline) ±hepatic venous pressure gradient (HVPG) measurement at the Vienna General Hospital between 2000-2019 were screened for PSVD and INCPH criteria. RESULTS: 91 patients were diagnosed with PSVD of which 28 (30.8%) also fulfilled INCPH criteria (INCPH+/PSVD+). Specific histological and specific clinical PH signs were found in 72 (79.1%) and 54 (59.3%) patients, respectively. INCPH+/PSVD+ showed higher Child-Pugh-scores (7±2 vs 6±1 points; P = .002) and a higher prevalence of decompensation (57.1% vs 28.6%; P = .009) than INCPH-/PSVD+ patients. Importantly, hepatic decompensation after three years (3Y) occurred in 11.2% of PSVD patients with specific clinical signs of PH, while no decompensation occurred in patients with only specific histological or with unspecific clinical/histological signs (P = .002). When categorizing by INCPH definition, 3Y decompensation was 13.4% in INCPH+/PSVD+ and 3.8% in INCPH-/PSVD+ (P = .120). While overall mortality was similar in INCPH+/PSVD+ (n = 6; 21.4%) and INCPH-/PSVD+ (n = 10; 15.9%) patients (P = .558), liver-related mortality tended to be higher in INCPH+/PSVD+ (6.9%) than in INCPH-/PSVD+ (0%; P = .078). CONCLUSION: Novel PSVD criteria facilitate diagnosis. Compared to INCPH, clinical course of PSVD patients is more favorable. Importantly, specific signs of PH including varices and collaterals are associated with hepatic decompensation and mortality.
引用
- Wöran K, Semmler G, Jachs M, et al. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol. 2020. PMID: 33279774. doi:10.1016/j.cgh.2020.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。